Transfection:
Plasmid Preparation:
Article Title: In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa.
Article Snippet: .. The vector was produced by Sanofi Genzyme (Framingham, MA) and was manufactured using a producer cell line based on HeLaS3 cells (ATCC CCL2.2) as described elsewhere16 and afterward purified by two-column vector purification using an AVB Sepharose HP column (GE Healthcare) followed by anion exchange chromatography.17 Virus particle concentration (*1 · 1013 vector genomes (vg) mL-1) was determined by TaqMan PCR assay.18 Balance salt solution (BSS) +0.014% Tween20 was used for formulation and vector dilution. .. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg; Medistar GmbH, Ascheberg, Germany) and xylazine (10 mg/kg, Xylariem ; Ecuphar GmbH, Greifswald, Germany) and pupils were dilated by tropicamide eye drops (Mydriaticum Stulln, Pharma Stulln GmbH, Stulln, Germany).
Suspension:
Produced:
Article Title: In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa.
Article Snippet: .. The vector was produced by Sanofi Genzyme (Framingham, MA) and was manufactured using a producer cell line based on HeLaS3 cells (ATCC CCL2.2) as described elsewhere16 and afterward purified by two-column vector purification using an AVB Sepharose HP column (GE Healthcare) followed by anion exchange chromatography.17 Virus particle concentration (*1 · 1013 vector genomes (vg) mL-1) was determined by TaqMan PCR assay.18 Balance salt solution (BSS) +0.014% Tween20 was used for formulation and vector dilution. .. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg; Medistar GmbH, Ascheberg, Germany) and xylazine (10 mg/kg, Xylariem ; Ecuphar GmbH, Greifswald, Germany) and pupils were dilated by tropicamide eye drops (Mydriaticum Stulln, Pharma Stulln GmbH, Stulln, Germany).
Cell Culture:Article Title: Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin
Article Snippet: .. The sample cells were HeLaS3 cells (ATCC CCL2.2), a cultured cell line derived from human cervical cancer. .. These HeLaS3 cells (ATCC CCL2.2) are known as a genomically unstable cultured cell line, which has been confirmed to have multiple chromosome duplications or in other words chromosomal abnormalities (karyotypic abnormalities).
Article Title: A defective viral genome strategy elicits broad protective immunity against respiratory viruses
Article Snippet: .. HeLaS3 cells (ATCC, CCL-2.2), Calu-3 cells (ATCC, HTB-55), A549-Ace2 cells were cultured in DMEM high glucose/F12 medium supplemented with 10% fetal bovine serum (Sigma) and 1x penicillin/streptomycin/glutamine (100xPSG, GIBCO). .. Packaging cell line: HelaS3 cells stable overexpression poliovirus P1 gene (HelaS3/P1) were cultured in DMEM high glucose/F12 medium supplemented with 10% fetal bovine serum (Sigma) and 1x penicillin/streptomycin/glutamine (100xPSG, GIBCO) plus 0.015% Zeocin (Invitrogen).
Derivative Assay:Article Title: Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin
Article Snippet: .. The sample cells were HeLaS3 cells (ATCC CCL2.2), a cultured cell line derived from human cervical cancer. .. These HeLaS3 cells (ATCC CCL2.2) are known as a genomically unstable cultured cell line, which has been confirmed to have multiple chromosome duplications or in other words chromosomal abnormalities (karyotypic abnormalities).
Modification:
Purification:Article Title: In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa.
Article Snippet: .. The vector was produced by Sanofi Genzyme (Framingham, MA) and was manufactured using a producer cell line based on HeLaS3 cells (ATCC CCL2.2) as described elsewhere16 and afterward purified by two-column vector purification using an AVB Sepharose HP column (GE Healthcare) followed by anion exchange chromatography.17 Virus particle concentration (*1 · 1013 vector genomes (vg) mL-1) was determined by TaqMan PCR assay.18 Balance salt solution (BSS) +0.014% Tween20 was used for formulation and vector dilution. .. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg; Medistar GmbH, Ascheberg, Germany) and xylazine (10 mg/kg, Xylariem ; Ecuphar GmbH, Greifswald, Germany) and pupils were dilated by tropicamide eye drops (Mydriaticum Stulln, Pharma Stulln GmbH, Stulln, Germany).
Chromatography:Article Title: In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa.
Article Snippet: .. The vector was produced by Sanofi Genzyme (Framingham, MA) and was manufactured using a producer cell line based on HeLaS3 cells (ATCC CCL2.2) as described elsewhere16 and afterward purified by two-column vector purification using an AVB Sepharose HP column (GE Healthcare) followed by anion exchange chromatography.17 Virus particle concentration (*1 · 1013 vector genomes (vg) mL-1) was determined by TaqMan PCR assay.18 Balance salt solution (BSS) +0.014% Tween20 was used for formulation and vector dilution. .. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg; Medistar GmbH, Ascheberg, Germany) and xylazine (10 mg/kg, Xylariem ; Ecuphar GmbH, Greifswald, Germany) and pupils were dilated by tropicamide eye drops (Mydriaticum Stulln, Pharma Stulln GmbH, Stulln, Germany).
Virus:Article Title: In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa.
Article Snippet: .. The vector was produced by Sanofi Genzyme (Framingham, MA) and was manufactured using a producer cell line based on HeLaS3 cells (ATCC CCL2.2) as described elsewhere16 and afterward purified by two-column vector purification using an AVB Sepharose HP column (GE Healthcare) followed by anion exchange chromatography.17 Virus particle concentration (*1 · 1013 vector genomes (vg) mL-1) was determined by TaqMan PCR assay.18 Balance salt solution (BSS) +0.014% Tween20 was used for formulation and vector dilution. .. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg; Medistar GmbH, Ascheberg, Germany) and xylazine (10 mg/kg, Xylariem ; Ecuphar GmbH, Greifswald, Germany) and pupils were dilated by tropicamide eye drops (Mydriaticum Stulln, Pharma Stulln GmbH, Stulln, Germany).
Concentration Assay:Article Title: In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa.
Article Snippet: .. The vector was produced by Sanofi Genzyme (Framingham, MA) and was manufactured using a producer cell line based on HeLaS3 cells (ATCC CCL2.2) as described elsewhere16 and afterward purified by two-column vector purification using an AVB Sepharose HP column (GE Healthcare) followed by anion exchange chromatography.17 Virus particle concentration (*1 · 1013 vector genomes (vg) mL-1) was determined by TaqMan PCR assay.18 Balance salt solution (BSS) +0.014% Tween20 was used for formulation and vector dilution. .. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg; Medistar GmbH, Ascheberg, Germany) and xylazine (10 mg/kg, Xylariem ; Ecuphar GmbH, Greifswald, Germany) and pupils were dilated by tropicamide eye drops (Mydriaticum Stulln, Pharma Stulln GmbH, Stulln, Germany).
Polymerase Chain Reaction:Article Title: In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa.
Article Snippet: .. The vector was produced by Sanofi Genzyme (Framingham, MA) and was manufactured using a producer cell line based on HeLaS3 cells (ATCC CCL2.2) as described elsewhere16 and afterward purified by two-column vector purification using an AVB Sepharose HP column (GE Healthcare) followed by anion exchange chromatography.17 Virus particle concentration (*1 · 1013 vector genomes (vg) mL-1) was determined by TaqMan PCR assay.18 Balance salt solution (BSS) +0.014% Tween20 was used for formulation and vector dilution. .. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg; Medistar GmbH, Ascheberg, Germany) and xylazine (10 mg/kg, Xylariem ; Ecuphar GmbH, Greifswald, Germany) and pupils were dilated by tropicamide eye drops (Mydriaticum Stulln, Pharma Stulln GmbH, Stulln, Germany).
Formulation:Article Title: In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa.
Article Snippet: .. The vector was produced by Sanofi Genzyme (Framingham, MA) and was manufactured using a producer cell line based on HeLaS3 cells (ATCC CCL2.2) as described elsewhere16 and afterward purified by two-column vector purification using an AVB Sepharose HP column (GE Healthcare) followed by anion exchange chromatography.17 Virus particle concentration (*1 · 1013 vector genomes (vg) mL-1) was determined by TaqMan PCR assay.18 Balance salt solution (BSS) +0.014% Tween20 was used for formulation and vector dilution. .. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg; Medistar GmbH, Ascheberg, Germany) and xylazine (10 mg/kg, Xylariem ; Ecuphar GmbH, Greifswald, Germany) and pupils were dilated by tropicamide eye drops (Mydriaticum Stulln, Pharma Stulln GmbH, Stulln, Germany).
|